NPI: 1336181452 · CHARLOTTE, NC 28262 · Sports Medicine (Family Medicine) Physician · NPI assigned 06/12/2006
Authorized official WALTON, LEEA controls 20+ related entities in our dataset. Read more
| Authorized Official | WALTON, LEEA (RCS MANAGER) |
| NPI Enumeration Date | 06/12/2006 |
Other providers sharing the same authorized official: WALTON, LEEA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,362 | $132K |
| 2019 | 4,615 | $211K |
| 2020 | 2,235 | $130K |
| 2021 | 12,391 | $300K |
| 2022 | 22,580 | $420K |
| 2023 | 20,646 | $488K |
| 2024 | 15,599 | $193K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6,729 | 6,190 | $519K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8,639 | 7,087 | $471K |
| 99051 | 7,399 | 6,421 | $173K | |
| 99199 | Unlisted special service, procedure or report | 43,963 | 43,034 | $155K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2,212 | 2,023 | $132K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,176 | 1,927 | $98K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2,767 | 2,528 | $78K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,007 | 840 | $78K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 642 | 584 | $72K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,617 | 2,835 | $65K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,252 | 630 | $17K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 553 | 531 | $7K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 94 | 66 | $3K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 49 | 30 | $2K |
| 99215 | Prolong outpt/office vis | 13 | 12 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 42 | 31 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 62 | 56 | $400.06 |
| 87807 | 26 | 26 | $343.36 | |
| 96127 | 86 | 85 | $325.09 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 54 | 48 | $315.54 |
| 81003 | 14 | 12 | $14.77 | |
| 99173 | 32 | 24 | $9.14 |